Scienture Holdings, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved its liquid formulation of losartan, branded as ArbliTM (losartan potassium) Oral Suspension, at a ...
Scienture's Arbli losartan oral suspension gains access to over 100 million covered lives through national commercial and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback